Financial Review: Tenon Medical (NASDAQ:TNON) versus Positron (OTCMKTS:POSC)

Tenon Medical (NASDAQ:TNONGet Free Report) and Positron (OTCMKTS:POSCGet Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, dividends, earnings and risk.

Insider and Institutional Ownership

22.7% of Tenon Medical shares are owned by institutional investors. 0.3% of Tenon Medical shares are owned by insiders. Comparatively, 17.2% of Positron shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and target prices for Tenon Medical and Positron, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tenon Medical 1 0 2 0 2.33
Positron 0 0 0 0 0.00

Tenon Medical currently has a consensus price target of $3.00, indicating a potential upside of 340.33%. Given Tenon Medical’s stronger consensus rating and higher possible upside, research analysts clearly believe Tenon Medical is more favorable than Positron.

Profitability

This table compares Tenon Medical and Positron’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Tenon Medical -396.26% -409.04% -114.60%
Positron N/A -311.50% -89.54%

Earnings & Valuation

This table compares Tenon Medical and Positron”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Tenon Medical $3.28 million 2.31 -$13.67 million ($1.77) -0.38
Positron $590,000.00 109.73 -$2.39 million ($0.12) -16.48

Positron has lower revenue, but higher earnings than Tenon Medical. Positron is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Tenon Medical has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Comparatively, Positron has a beta of 0.72, suggesting that its share price is 28% less volatile than the S&P 500.

About Tenon Medical

(Get Free Report)

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

About Positron

(Get Free Report)

Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.

Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.